EurekaMag.com logo
+ Site Statistics
References:
53,214,146
Abstracts:
29,074,682
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on Google+Follow on Google+
Follow on LinkedInFollow on LinkedIn

+ Translate

Effect of propranolol on myocardial ischemia occurring during acute coronary occlusion


Circulation 73(4): 727-733
Effect of propranolol on myocardial ischemia occurring during acute coronary occlusion
In 16 patients undergoing angioplasty of the left anterior descending coronary artery, the clinical, electrocardiographic, and hemodynamic effects of short-term intravenous nonselective beta-adrenergic blockade with propranolol (0.1 mg/kg) were assessed during temporary occlusion of the artery. Myocardial ischemia during coronary occlusion was prevented, delayed in onset, or diminished in magnitude by propranolol in 10 of the 16 patients. Propranolol decreased values for indexes of myocardial oxygen demand, such as heart rate and blood pressure and their product, in all patients. Surprisingly, in patients who derived clinical benefit, propranolol did not change indexes of myocardial oxygen supply to the left ventricular region perfused by the occluded artery. For example, great cardiac vein flow (40 +/- 15 to 41 +/- 17 ml/min, p = NS) and coronary collateral resistance (2.1 +/- 1.0 to 2.1 +/- 1.1 mm Hg/ml/min, p = NS) were unchanged. In contrast, a worsening of supply occurred in patients who were not benefited: great cardiac vein flow (50 +/- 10 to 39 +/- 6 ml/min, p less than .05) decreased and coronary collateral resistance (1.6 +/- 0.5 to 2.0 +/- 0.6 mm Hg/ml/min, p less than .05) increased. Information obtained from this study demonstrates the value of this new experimental preparation in helping assess potential clinical effectiveness of drug interventions during the initial phase of acute coronary occlusion and providing insight into the mechanisms of drug effect.

(PDF same-day service: $19.90)

Accession: 005264650

PMID: 2936533

DOI: 10.1161/01.CIR.73.4.727



Related references

Effect of nicardipine on determinants of myocardial ischemia occurring during acute coronary occlusion produced by percutaneous transluminal coronary angioplasty. American Journal of Cardiology 60(4): 267-270, 1987

Effect of propranolol on myocardial ischemia during coronary occlusion in man. American Heart Association Monograph (107): II-300, 1984

Effect of intracoronary verapamil and propranolol on st segment elevation occurring during acute coronary occlusion. Japanese Circulation Journal 52(8): 728, 1988

The effect of a beta blocker propranolol obsidan on macroergic phosphates and the size of developing myocardial necrotic area in acute coronary occlusion an experimental study. Kardiologiya 28(8): 86-90, 1988

Effect of propranolol on ischemic myocardial damage and left ventricular hypertrophy following permanent coronary artery occlusion or occlusion followed by reperfusion. Pharmacology 38(5): 298-309, 1989

Effect of coronary sinus occlusion on coronary circulation and hemodynamics 1. effect of coronary sinus occlusion on coronary hemodynamics and incidence of ventricular fibrillation during acute myo cardial ischemia in dogs. Okayama Igakkai Zasshi 96(1-2): 87-99, 1984

The significance of stenotic lesion in an unoccluded coronary artery. A manifestation of myocardial "ischemia at a distance" during acute coronary occlusion. Japanese Circulation Journal 46(10): 1073-1081, 1982

Regional Myocardial function in the conscious dog during acute coronary occlusion and responses to morphine, propranolol, nitroglycerin, and lidocaine. Circulation 53(2): 302-314, 1976

Comparison of ST-segment deviation to scintigraphically quantified myocardial ischemia during acute coronary occlusion induced by percutaneous transluminal coronary angioplasty. American Journal of Cardiology 97(3): 295-300, 2006

Effect of tranquilizers on the course of myocardial ischemia and on myocardial resistance to hypoxia in coronary artery occlusion. Farmakologiia i Toksikologiia 46(1): 38-41, 1983